⚕ GalenOps CRO console
← 710 (USA)

710-1271

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2012-09-27
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ATRIAL FIBRILLATION — outcome: RECOVERED/RESOLVED; onset 2012-11-21 (study day 56.0); relationship: POSSIBLE; serious criteria: hospitalization, life-threatening

moderate assessed 2026-08-18

Moderate CARDIAC FAILURE CONGESTIVE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-22 (study day 57.0); relationship: POSSIBLE; serious criteria: hospitalization, life-threatening

moderate assessed 2026-08-18

Moderate DYSPNOEA — outcome: RECOVERED/RESOLVED; onset 2012-11-21 (study day 56.0); relationship: POSSIBLE; serious criteria: hospitalization

moderate assessed 2026-08-18

Moderate HYPONATRAEMIA — outcome: RECOVERED/RESOLVED; onset 2012-11-22 (study day 57.0); relationship: REMOTE; serious criteria: hospitalization

severe assessed 2026-08-18

Severe MYOCARDIAL INFARCTION — outcome: RECOVERED/RESOLVED; onset 2012-11-21 (study day 56.0); relationship: POSSIBLE; serious criteria: hospitalization, life-threatening

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.